Mark Tumblin

Nivolumab in the Treatment of Recurrent or Refractory Pediatric Brain Tumors: A Single Institutional Experience

J. Crawford, D. Malicki, M. Milburn, 2019, Journal of pediatric hematology/oncology.

Single‐agent bevacizumab in the treatment of recurrent or refractory pediatric low‐grade glioma: A single institutional experience

J. Crawford, P. Khanna, M. Milburn, 2018, Pediatric blood & cancer.

Use of hyperbaric oxygen therapy in pediatric neuro-oncology: a single institutional experience

J. Crawford, Yasmin Aghajan, I. Grover, 2018, Journal of Neuro-Oncology.